274 related articles for article (PubMed ID: 21658006)
1. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
[TBL] [Abstract][Full Text] [Related]
2. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
4. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.
Takeno S; Yamashita S; Takahashi Y; Ono K; Kamei M; Moroga T; Kawahara K
Eur J Cardiothorac Surg; 2010 Feb; 37(2):440-5. PubMed ID: 19699104
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
Kurashige J; Kamohara H; Watanabe M; Tanaka Y; Kinoshita K; Saito S; Hiyoshi Y; Iwatsuki M; Baba Y; Baba H
J Surg Oncol; 2012 Aug; 106(2):188-92. PubMed ID: 22354855
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J
Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326
[TBL] [Abstract][Full Text] [Related]
10. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
11. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
[TBL] [Abstract][Full Text] [Related]
12. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
13. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
[TBL] [Abstract][Full Text] [Related]
16. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
17. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Liu H; Shi G; Liu X; Wu H; Fan Q; Wang X
Oncol Rep; 2011 Mar; 25(3):841-8. PubMed ID: 21186404
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.
de A Simão T; Souza-Santos PT; de Oliveira DS; Bernardo V; Lima SC; Rapozo DC; Kruel CD; Faria PA; Ribeiro Pinto LF; Albano RM
Exp Mol Pathol; 2011 Oct; 91(2):584-9. PubMed ID: 21777580
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
